{"id":19035,"date":"2025-08-05T02:33:55","date_gmt":"2025-08-05T02:33:55","guid":{"rendered":"https:\/\/finderica.com\/?p=19035"},"modified":"2025-08-05T02:33:55","modified_gmt":"2025-08-05T02:33:55","slug":"pltr-hims-vrtx-and-more","status":"publish","type":"post","link":"https:\/\/finderica.com\/?p=19035","title":{"rendered":"PLTR, HIMS, VRTX and more"},"content":{"rendered":"<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making headlines in extended trading: Palantir \u2014 The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street&#8217;s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1 billion in revenue, while analysts polled by LSEG anticipated 14 cents in earnings per share and $940 million in revenue. Vertex Pharmaceuticals \u2014 The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 in earnings per share and $2.91 billion in revenue. Hims &amp; Hers Health \u2014 Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals \u2014 The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million and $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products \u2014 The vehicle parts supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X \u2014 Shares rose more than 2% after the aerospace and defense company&#8217;s second-quarter results beat Wall Street&#8217;s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company&#8217;s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre \u2014 Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. \u2014 CNBC&#8217;s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting.<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"><\/span><\/p>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/www.cnbc.com\/2025\/08\/04\/stocks-making-the-biggest-moves-after-hours-pltr-hims-vrtx-and-more.html\" target=\"_blank\" rel=\"noopener\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making headlines in extended trading: Palantir \u2014 The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street&#8217;s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1 billion in revenue, while analysts polled by LSEG anticipated 14 cents in earnings per share and $940 million<\/p>\n","protected":false},"author":1,"featured_media":19036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[196],"tags":[4273,2054,3512],"class_list":{"0":"post-19035","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-finance-news","8":"tag-hims","9":"tag-pltr","10":"tag-vrtx"},"_links":{"self":[{"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/posts\/19035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/finderica.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19035"}],"version-history":[{"count":0,"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/posts\/19035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finderica.com\/index.php?rest_route=\/wp\/v2\/media\/19036"}],"wp:attachment":[{"href":"https:\/\/finderica.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finderica.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finderica.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}